Francesco Morra
Via Pansini, 5
Naples, Italy
Naples, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
KRAS-mediated CCDC6 degradation drives xCT upregulation and ferroptosis evasion.
Journal: Apoptosis : an international journal on programmed cell death
Published: May 18, 2026
CCDC6 Immunostaining in Conjunction with the Rad51 HRD Assay May Expand PARPi Treatment Eligibility in Patients with HGSOC.
Journal: Cancer research communications
Published: August 04, 2025
A xCT role in tumour-associated ferroptosis shed light on novel therapeutic options.
Journal: Exploration of targeted anti-tumor therapy
Published: May 13, 2022
The disruption of the CCDC6 - PP4 axis induces a BRCAness like phenotype and sensitivity to PARP inhibitors in high-grade serous ovarian carcinoma.
Journal: Journal of experimental & clinical cancer research : CR
Published: March 04, 2022
Thyroid hormone and androgen signals mutually interplay and enhance inflammation and tumorigenic activation of tumor microenvironment in prostate cancer.
Journal: Cancer letters
Published: July 28, 2021
Retraction Note: Critical role of CCDC6 in the neoplastic growth of testicular germ cell tumors.
Journal: BMC cancer
Published: January 28, 2021
Identification of Novel Biomarkers of Homologous Recombination Defect in DNA Repair to Predict Sensitivity of Prostate Cancer Cells to PARP-Inhibitors.
Journal: International journal of molecular sciences
Published: May 13, 2019
Last Updated: 09/26/2026